Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $29.3 million.

  • Cross Country Healthcare's Other Accumulated Expenses fell 1612.64% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.3 million, marking a year-over-year decrease of 1612.64%. This contributed to the annual value of $34.4 million for FY2024, which is 122.8% down from last year.
  • As of Q3 2025, Cross Country Healthcare's Other Accumulated Expenses stood at $29.3 million, which was down 1612.64% from $30.3 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Other Accumulated Expenses ranged from a high of $35.9 million in Q1 2023 and a low of $24.6 million during Q1 2021
  • Its 5-year average for Other Accumulated Expenses is $31.1 million, with a median of $32.7 million in 2023.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 4174.37% in 2022, then crashed by 1612.64% in 2025.
  • Over the past 5 years, Cross Country Healthcare's Other Accumulated Expenses (Quarter) stood at $25.3 million in 2021, then soared by 41.74% to $35.9 million in 2022, then fell by 2.87% to $34.9 million in 2023, then fell by 1.23% to $34.4 million in 2024, then fell by 14.99% to $29.3 million in 2025.
  • Its last three reported values are $29.3 million in Q3 2025, $30.3 million for Q2 2025, and $34.0 million during Q1 2025.